Conduit Pharmaceuticals Inc. (CDT)

Conduit Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021
Cash & Equivalents	4.23	0	0
Cash & Cash Equivalents	4.23	0	0
Other Current Assets	1.51	0	0.1
Total Current Assets	5.73	0	0.1
Goodwill and Intangibles	0	0.01	0
Other Long-Term Assets	1.49	0	0.11
Total Long-Term Assets	1.49	0.01	0.11
Total Assets	7.22	0.01	0
Accounts Payable	0.22	0	0
Deferred Revenue	0	0	2.96
Current Debt	0.99	0.18	0
Other Current Liabilities	0.6	4	-0.72
Total Current Liabilities	1.8	4.18	2.24
Long-Term Debt	0	5.92	0.75
Other Long-Term Liabilities	5.88	0	2.96
Total Long-Term Liabilities	5.88	5.92	3.71
Total Liabilities	7.68	10.09	5.94
Total Debt	0.99	6.09	0.75
Debt Growth	-83.83%	713.48%	-
Retained Earnings	-11.3	-10.77	-5.88
Comprehensive Income	0.41	0.68	-0.07
Shareholders' Equity	-0.46	-10.09	-5.94
Net Cash / Debt	3.24	-6.09	-0.75
Net Cash Per Share	0.05	-0.16	-0.00
Working Capital	3.93	-4.18	-2.13
Book Value Per Share	-0.01	-0.27	-0.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).